Chr.Hansen, Inc.
Wausau, WI, United States
Due-diligence reportFind an accredited testing lab and confirm its scope covers your product and methods.
Chr.Hansen, Inc. is a dietary supplement manufacturer in Wausau, WI, United States, certified to NSF/ANSI 455-2 GMP, with 2 manufacturing facilities on NSF’s public NSF/ANSI 455 listing as of November 19, 2026. It is also a USDA Organic certified operation. Listed dosage forms: capsules, powders and tablets.
- Website
- novonesis.com
- Phone
- 715-849-3333
- Facilities listed
- 2
- Last checked
Dosage forms
As listed in the product categories of this company’s NSF/ANSI 455-2 certified facilities.
Products on its USDA Organic certificate
Product types among the organic items that Chr.Hansen, Inc.’s certified operation lists in the USDA Organic Integrity Database.
Probiotics1 item
- Fitbiotic Probiotic Supplement
As written in the USDA Organic Integrity Database.
Probiotic manufacturers →
USDA Organic Integrity Database, operation 5870106509, checked .
These are organic items only: the certificate says nothing about the company’s non-organic products. A listed item is the certifier’s record of what the operation is certified to handle organically, not a test of the product. About USDA Organic item lists
Certified facilities
Manufacturing (2)
555 North 72nd Avenue, Wausau, WI 54401, United States
- Dry Formulation
- Encapsulation
- Mixing
- Packaging/Labeling Operation
- Packaging/Labeling Operation - Bulk Packaging
- Packaging/Labeling Operation - Primary Packaging
- Packaging/Labeling Operation - Secondary Packaging
- Quality Unit Operations
- Tablet Compression
- Warehousing
7333 Stewart Ave, Wausau, WI 54401, United States
- Warehousing
How Chr.Hansen, Inc. compares
Among the 769 manufacturers we list, as of our last check.
- One of 6 capsule manufacturers we list in Wisconsin, and 325 in the United States. All capsule manufacturers in the USA · All in Wisconsin
- One of 4 tablet manufacturers we list in Wisconsin, and 228 in the United States. All tablet manufacturers in the USA
- One of 5 powder manufacturers we list in Wisconsin, and 316 in the United States. All powder manufacturers in the USA · All in Wisconsin
- On 2 of the registries we check: NSF/ANSI 455-2 and USDA Organic. 165 of the 769 manufacturers we list are on 2 or more.
- Has 2 listed manufacturing or packaging facilities; 71% of the manufacturers we list have fewer.
FDA recall records
No food or dietary supplement recall found under the name Chr.Hansen, Inc. in FDA’s enforcement reports, as of .
We match FDA records by company name only. A recall listed under a different name won’t appear here, and a different company with the same name could. FDA’s food enforcement records start in June 2012. How we check
FDA inspections
FDA lists 9 food or dietary supplement inspections at facilities matching Chr.Hansen, Inc., from 2009 to 2021, as of . 2 found no objectionable conditions, 3 found conditions the firm was left to correct, and 4 led FDA to recommend official action.
No action indicated · No objectionable conditions found
Inspected
Wausau, Wisconsin
Listed by FDA as Chr-Hansen - Wausau
FEI 3004060046
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Wausau, Wisconsin
Listed by FDA as Chr-Hansen - Wausau
2 citations posted:
- Written procedures - quality control operations (21 CFR 111.103)
- Laboratory methodology followed (21 CFR 111.325(b)(2))
Full citation text
Written procedures - quality control operations (21 CFR 111.103)
You did not establish and follow written procedures for quality control operations.
Laboratory methodology followed (21 CFR 111.325(b)(2))
You did not make and keep documentation that established laboratory methodology was followed.
FEI 3004060046
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Wausau, Wisconsin
Listed by FDA as Chr-Hansen - Wausau
FEI 3004060046
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Wausau, Wisconsin
Listed by FDA as Chr-Hansen - Wausau
8 citations posted:
- Physical plant - material review and disposition (21 CFR 111.20(c)(2))
- Specifications met identity,purity, strength, comp,; basis (21 CFR 111.75(c)(3))
- Packaging description, representative label (21 CFR 111.210(g))
- Instructions; specifications; quality (21 CFR 111.210(h)(1))
See all 8 citations
Physical plant - material review and disposition (21 CFR 111.20(c)(2))
You did not have separate or defined areas of adequate size or other control systems to prevent contamination or mix-ups of components or dietary supplements by separating components, dietary supplements, packaging, and labels that are to be used in manufacturing from those that are awaiting material review and disposition decision, reprocessing, or disposal.
Specifications met identity,purity, strength, comp,; basis (21 CFR 111.75(c)(3))
You did not provide adequate documentation of your basis for determining that compliance with the specificatio s you selected for identity, purity, strength, and composition will ensure that the finished batch of dietary supplement meets the specificatio s.
Packaging description, representative label (21 CFR 111.210(g))
Your master manufacturing record did not include a description of the packaging and a representative label, or a cross-reference to the physical location of the actual or representative label.
Instructions; specifications; quality (21 CFR 111.210(h)(1))
The written instructions in your master manufacturing record did not include specifications for each point, step, or stage in the manufacturing process where control is necessary to ensure the quality of the dietary supplement.
Master manufacturing record - sampling, tests, examinations (21 CFR 111.210(h)(2))
The written instructions in your master manufacturing record did not include procedures for sampling and a cross-reference to procedures for tests or examinations.
Corrective action plans (21 CFR 111.210(h)(5))
The written instructions in your master manufacturing did not include instructions for corrective action plans to use when specifications are not met.
Batch record - follow master (21 CFR 111.255(c))
Your batch production record did not accurately follow the appropriate master manufacturing record.
Manufacturing operations - sanitation (21 CFR 111.360)
You did not conduct manufacturing operations in accordance with adequate sanitation principles.
FEI 3004060046
Official action indicated · Regulatory or administrative action recommended
Inspected
Wausau, Wisconsin
Listed by FDA as Chr-Hansen - Wausau
9 citations posted:
- Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))
- QC specification, identity, purity, strength, composition (21 CFR 111.70(c)(3))
- Specifications - labels, packaging (21 CFR 111.70(d))
- Tests, examinations - scientifically valid (21 CFR 111.75(h))
See all 9 citations
Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))
You did not establish component specifications for purity, strength, and composition.
QC specification, identity, purity, strength, composition (21 CFR 111.70(c)(3))
Your quality control personnel did not review and approve the documentation of your basis for why meeting the in-process specifications, in combination with meeting component specifications, will help ensure that the specifications are met for the identity, purity, strength, and composition of the dietary supplements.
Specifications - labels, packaging (21 CFR 111.70(d))
You did not establish label and packaging specifications.
Tests, examinations - scientifically valid (21 CFR 111.75(h))
You did not ensure that the tests or examinations that you used to determine whether the specifications are met are appropriate, scientifically valid methods.
Written procedures - quality control operations (21 CFR 111.103)
You did not establish written procedures for quality control operations.
Instructions; specifications; quality (21 CFR 111.210(h)(1))
The written instructions in your master manufacturing record did not include specifications for each point, step, or stage in the manufacturing process where control is necessary to ensure the quality of the dietary supplement.
Batch record - results; monitoring (21 CFR 111.260(g))
Your batch production records did not include the actual results obtained during a monitoring operation.
Batch record - approved, released, rejected; batch (21 CFR 111.260(l)(3))
Your batch production records did not include documentation that quality control personnel approved and released, or rejected, a batch for distribution.
Laboratory methodology followed (21 CFR 111.325(b)(2))
You did not make and keep documentation that established laboratory methodology was followed.
FEI 3004060046
Show all 9 inspections
No action indicated · No objectionable conditions found
Inspected
Wausau, Wisconsin
Listed by FDA as Chr-Hansen - Wausau
FEI 3004060046
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Wausau, Wisconsin
Listed by FDA as Chr-Hansen - Wausau
2 citations posted:
- Written procedures - quality control operations (21 CFR 111.103)
- Laboratory methodology followed (21 CFR 111.325(b)(2))
Full citation text
Written procedures - quality control operations (21 CFR 111.103)
You did not establish and follow written procedures for quality control operations.
Laboratory methodology followed (21 CFR 111.325(b)(2))
You did not make and keep documentation that established laboratory methodology was followed.
FEI 3004060046
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Wausau, Wisconsin
Listed by FDA as Chr-Hansen - Wausau
FEI 3004060046
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Wausau, Wisconsin
Listed by FDA as Chr-Hansen - Wausau
8 citations posted:
- Physical plant - material review and disposition (21 CFR 111.20(c)(2))
- Specifications met identity,purity, strength, comp,; basis (21 CFR 111.75(c)(3))
- Packaging description, representative label (21 CFR 111.210(g))
- Instructions; specifications; quality (21 CFR 111.210(h)(1))
See all 8 citations
Physical plant - material review and disposition (21 CFR 111.20(c)(2))
You did not have separate or defined areas of adequate size or other control systems to prevent contamination or mix-ups of components or dietary supplements by separating components, dietary supplements, packaging, and labels that are to be used in manufacturing from those that are awaiting material review and disposition decision, reprocessing, or disposal.
Specifications met identity,purity, strength, comp,; basis (21 CFR 111.75(c)(3))
You did not provide adequate documentation of your basis for determining that compliance with the specificatio s you selected for identity, purity, strength, and composition will ensure that the finished batch of dietary supplement meets the specificatio s.
Packaging description, representative label (21 CFR 111.210(g))
Your master manufacturing record did not include a description of the packaging and a representative label, or a cross-reference to the physical location of the actual or representative label.
Instructions; specifications; quality (21 CFR 111.210(h)(1))
The written instructions in your master manufacturing record did not include specifications for each point, step, or stage in the manufacturing process where control is necessary to ensure the quality of the dietary supplement.
Master manufacturing record - sampling, tests, examinations (21 CFR 111.210(h)(2))
The written instructions in your master manufacturing record did not include procedures for sampling and a cross-reference to procedures for tests or examinations.
Corrective action plans (21 CFR 111.210(h)(5))
The written instructions in your master manufacturing did not include instructions for corrective action plans to use when specifications are not met.
Batch record - follow master (21 CFR 111.255(c))
Your batch production record did not accurately follow the appropriate master manufacturing record.
Manufacturing operations - sanitation (21 CFR 111.360)
You did not conduct manufacturing operations in accordance with adequate sanitation principles.
FEI 3004060046
Official action indicated · Regulatory or administrative action recommended
Inspected
Wausau, Wisconsin
Listed by FDA as Chr-Hansen - Wausau
9 citations posted:
- Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))
- QC specification, identity, purity, strength, composition (21 CFR 111.70(c)(3))
- Specifications - labels, packaging (21 CFR 111.70(d))
- Tests, examinations - scientifically valid (21 CFR 111.75(h))
See all 9 citations
Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))
You did not establish component specifications for purity, strength, and composition.
QC specification, identity, purity, strength, composition (21 CFR 111.70(c)(3))
Your quality control personnel did not review and approve the documentation of your basis for why meeting the in-process specifications, in combination with meeting component specifications, will help ensure that the specifications are met for the identity, purity, strength, and composition of the dietary supplements.
Specifications - labels, packaging (21 CFR 111.70(d))
You did not establish label and packaging specifications.
Tests, examinations - scientifically valid (21 CFR 111.75(h))
You did not ensure that the tests or examinations that you used to determine whether the specifications are met are appropriate, scientifically valid methods.
Written procedures - quality control operations (21 CFR 111.103)
You did not establish written procedures for quality control operations.
Instructions; specifications; quality (21 CFR 111.210(h)(1))
The written instructions in your master manufacturing record did not include specifications for each point, step, or stage in the manufacturing process where control is necessary to ensure the quality of the dietary supplement.
Batch record - results; monitoring (21 CFR 111.260(g))
Your batch production records did not include the actual results obtained during a monitoring operation.
Batch record - approved, released, rejected; batch (21 CFR 111.260(l)(3))
Your batch production records did not include documentation that quality control personnel approved and released, or rejected, a batch for distribution.
Laboratory methodology followed (21 CFR 111.325(b)(2))
You did not make and keep documentation that established laboratory methodology was followed.
FEI 3004060046
Official action indicated · Regulatory or administrative action recommended
Inspected
Wausau, Wisconsin
Listed by FDA as Chr-Hansen - Wausau
14 citations posted:
- Personnel - records - training (21 CFR 111.14(b)(2))
- Physical plant - design and construction (21 CFR 111.20(d))
- Records - water (21 CFR 111.23(c))
- Component - verify identity, dietary ingredient (21 CFR 111.75(a)(1)(i))
See all 14 citations
Personnel - records - training (21 CFR 111.14(b)(2))
You did not make and keep documentation of training.
Physical plant - design and construction (21 CFR 111.20(d))
Your physical plant was not designed in a manner that prevents contamination of components, dietary supplements, or contact surfaces.
Records - water (21 CFR 111.23(c))
You did not make and keep records that show that the water you use complies with applicable Federal, State, and local requirements and does not contaminate the dietary supplement.
Component - verify identity, dietary ingredient (21 CFR 111.75(a)(1)(i))
You did not conduct at least one appropriate test or examination to verify the identity of a dietary ingredient, prior to its use.
Specifications met - verify; finished batch (21 CFR 111.75(c))
You did not verify that your finished batch of dietary supplement meets product specifications for strength and composition.
Tests, examinations - scientifically valid (21 CFR 111.75(h))
You did not ensure that the tests or examinations that you used to determine whether the specifications are met are appropriate, scientifically valid methods.
Quality control operations - material review, disposition decision (21 CFR 111.120(c))
Your quality control operations did not include conducting a required material review and making a required disposition decision for components prior to their use.
Quality control - batch, product specifications (21 CFR 111.123(b)(2))
Your quality control personnel approved and released for distribution a batch of dietary supplement that did not meet established product specifications.
Instructions; specifications; quality (21 CFR 111.210(h)(1))
The written instructions in your master manufacturing record did not include specifications for each point, step, or stage in the manufacturing process where control is necessary to ensure the quality of the dietary supplement.
Batch record - results; monitoring (21 CFR 111.260(g))
Your batch production records did not include the actual results obtained during a monitoring operation.
Batch record - manufacture (21 CFR 111.260(j))
Your batch production records did not include documentation, at the time of performance, of the manufacture of the batch.
Batch record - approved, released, rejected; batch (21 CFR 111.260(l)(3))
Your batch production records did not include documentation that quality control personnel approved and released, or rejected, a batch for distribution.
Laboratory methodology followed (21 CFR 111.325(b)(2))
You did not make and keep documentation that established laboratory methodology was followed.
Hold - temperature, humidity, light (21 CFR 111.455(a))
You did not hold components and dietary supplements under appropriate conditions of temperature, humidity, or light so that their identity, purity, strength, and composition are not affected.
FEI 3004060046
Official action indicated · Regulatory or administrative action recommended
Inspected
Wausau, Wisconsin
Listed by FDA as Chr-Hansen - Wausau
15 citations posted:
- Personnel - education, training, experience (21 CFR 111.12(c))
- Physical plant - design and construction (21 CFR 111.20(d))
- Refrigerator, freezer - temperature recording device (21 CFR 111.27(a)(5)(i))
- Specifications - component identity (21 CFR 111.70(b)(1))
See all 15 citations
Personnel - education, training, experience (21 CFR 111.12(c))
Personnel engaged in packaging and labeling dietary supplements do not have the education, training, or experience to perform the person's assigned functions.
Physical plant - design and construction (21 CFR 111.20(d))
Your physical plant was not designed in a manner that prevents contamination of components, dietary supplements, or contact surfaces.
Refrigerator, freezer - temperature recording device (21 CFR 111.27(a)(5)(i))
Your freezer, refrigerator, or other cold storage compartment that you use to hold components or dietary supplements does not have an indicating thermometer, temperature-measuring device, or temperature-recording device that indicates and records, or allows for recording by hand, the accurate temperature within the compartment.
Specifications - component identity (21 CFR 111.70(b)(1))
You did not establish an identity specification for each component.
Specifications - identity, purity, strength, composition (21 CFR 111.70(e))
You did not establish product specifications for the identity, purity, strength, and composition of the finished dietary supplement.
Specifications met in-process purity, strength, composition (21 CFR 111.73)
You did not determine whether you met in-process specifications to ensure the strength and composition of the dietary supplements.
Component - verify identity, dietary ingredient (21 CFR 111.75(a)(1)(i))
You did not conduct at least one appropriate test or examination to verify the identity of a dietary ingredient, prior to its use.
Tests, examinations - scientifically valid (21 CFR 111.75(h))
You did not ensure that the tests or examinations that you used to determine whether the specifications are met are appropriate, scientifically valid methods.
Written procedures - quality control operations (21 CFR 111.103)
You did not follow written procedures for quality control operations.
Quality control operations - batch production records (21 CFR 111.123(a)(2))
Your quality control operations did not include reviewing and approving all batch production-related records.
Quality control - batch, product specifications (21 CFR 111.123(b)(2))
Your quality control personnel approved and released for distribution a batch of dietary supplement that did not meet established product specifications.
Master manufacturing record - controls, procedures (21 CFR 111.205(b)(2))
Your master manufacturing record did not establish controls and procedures to ensure that each batch met specifications.
Batch record - every batch (21 CFR 111.255(a))
You did not prepare a batch production record every time you manufactured a batch of dietary supplement.
Batch record - complete (21 CFR 111.255(b))
Your batch production record did not include complete information relating to the production and control of each batch.
Batch record - date, each step (21 CFR 111.260(j)(1))
Your batch production records did not include the date on which each step of the master manufacturing record was performed.
FEI 3004060046
Official action indicated · Regulatory or administrative action recommended
Inspected
Wausau, Wisconsin
Listed by FDA as Chr-Hansen - Wausau
11 citations posted:
- Personnel - quality control personnel - qualified (21 CFR 111.12)
- Physical plant - design and construction (21 CFR 111.20(d))
- Equipment - design - suitable (21 CFR 111.27(a))
- Refrigerator, freezer - temperature recording device (21 CFR 111.27(a)(5)(i))
See all 11 citations
Personnel - quality control personnel - qualified (21 CFR 111.12)
The personnel you identified to perform quality control operations do not have the education, training or experience to perform the assigned functions.
Physical plant - design and construction (21 CFR 111.20(d))
Your physical plant was not designed in a manner that prevents contamination of components, dietary supplements, or contact surfaces.
Equipment - design - suitable (21 CFR 111.27(a))
You did not use equipment or utensils of appropriate design, construction, and workmanship to enable them to be suitable for its intended use, adequately cleaned, and properly maintained.
Refrigerator, freezer - temperature recording device (21 CFR 111.27(a)(5)(i))
Your freezer, refrigerator, or other cold storage compartment that you use to hold components or dietary supplements does not have an indicating thermometer, temperature-measuring device, or temperature-recording device that indicates and records, or allows for recording by hand, the accurate temperature within the compartment.
Specifications - component identity (21 CFR 111.70(b)(1))
You did not establish an identity specification for each component.
Specifications-component purity, strength, composition (21 CFR 111.70(b)(2))
You did not establish component specifications for purity, strength, and composition.
Specifications - identity, purity, strength, composition (21 CFR 111.70(e))
You did not establish product specifications for the identity, purity, strength, and composition of the finished dietary supplement.
Component - qualify supplier (21 CFR 111.75(a)(2)(ii)(A))
You did not qualify a supplier of a component by establishing the reliability of the supplier's certificate of analysis through confirmation of the results of their tests or examinations.
Written procedures - quality control operations (21 CFR 111.103)
You did not follow written procedures for quality control operations.
Master manufacturing record - unique formulation (21 CFR 111.205(a))
You did not prepare a written master manufacturing record for each unique formulation of a dietary supplement that you manufactured.
Batch record - complete (21 CFR 111.255(b))
Your batch production record did not include complete information relating to the production and control of each batch.
FEI 3004060046
No action indicated · No objectionable conditions found
Inspected
Wausau, Wisconsin
Listed by FDA as Chr-Hansen - Wausau
FEI 3004060046
We match FDA inspections to companies by facility ZIP code (or city outside the US) and company name, so an inspection filed under a different name won’t appear here. FDA publishes final classifications only, and holds some back while enforcement is pending. Posted citations may differ from FDA’s final findings. FDA Data Dashboard · How we check
What Chr.Hansen, Inc. says it offers
From Chr.Hansen, Inc.’s own website, checked . Not verified by us.
Products
ProbioticsShow quoteHide quote“Our portfolio is manufactured at scale in-house and includes prebiotics, probiotics, enzymes, novel vitamins, proteins and many other biosolutions to help you meet people’s complex needs.”
“Our portfolio is manufactured at scale in-house and includes prebiotics, probiotics, enzymes, novel vitamins, proteins and many other biosolutions to help you meet people’s complex needs.”
Source page · seen on
We read the company’s public web pages and keep a claim only when its quote appears on the page. A claim is hidden once we haven’t seen it for 120 days. Spotted something wrong? Tell us · How we collect website claims
What we checked, and what we didn’t
Confirmed from public registry listings
Last checked
- NSF/ANSI 455-2 GMP certification
- USDA Organic certified operation
- 2 facility addresses
- Dosage forms in the certified scope
- Operations listed for each facility
- Product types on its USDA Organic certificate (organic items only)
Not verified by us
- Minimum order quantity (MOQ): the smallest order they accept
- Lead times and current capacity
- Prices
- Other certifications, like kosher, halal or NSF Certified for Sport
- Whether they’re taking new clients
- Conditions inside the facility. We don’t visit or audit facilities.
- What the company’s own website says it makes and offers, shown above with quotes
Ask about these in your quote request. How we verify
Other capsule manufacturers in the United States
NSF lists 5 capsule facilities, including one in Tempe, AZ
Tempe, AZ, United States21stcenturyvitamins.com
- Capsules
- Gummies
- Softgels
- Tablets
Operations:- Kitting
- Coating
- Tablet compression
- Encapsulation
NSF/ANSI 455-2checked Nov 19, 2026NSF lists a capsule facility in Centennial, CO
Centennial, CO, United States5280smc.com
- Capsules
Operations:- Encapsulation
- Dry formulation
NSF/ANSI 455-2checked Nov 19, 2026NSF lists a capsule facility in Garden Grove, CA
Garden Grove, CA, United Statespackaging.com
- Capsules
- Gummies
- Powders
- Softgels
- Tablets
NSF/ANSI 455-2checked Nov 19, 2026Access Business Group, LLC
USDA OrganicNSF lists a capsule facility in Ada, MI
Ada, MI, United Statesamway.com
- Capsules
- Powders
- Softgels
- Tablets
Operations:- Kitting
- Coating
- Tablet compression
- Encapsulation
- +1 more
NSF/ANSI 455-2checked Nov 19, 2026NSF lists 2 capsule facilities, including one in Chandler, AZ
Gilbert, AZ, United Statesadeptlifesciences.com
- Capsules
- Liquids
- Powders
- Tablets
Operations:- Liquid formulation
- Tablet compression
- Encapsulation
- Dry formulation
NSF/ANSI 455-2checked Nov 19, 2026ADH Health Products, Inc.
USDA OrganicNSF lists a capsule facility in Congers, NY
Congers, NY, United Statesadhhealth.com
- Capsules
- Oils
- Powders
- Tablets
Operations:- Coating
- Tablet compression
- Encapsulation
- Dry formulation
NSF/ANSI 455-2checked Nov 19, 2026